Marc Beer Boosts Renovia Inc. to Help Women with Pelvic Disorder

Marc Beer started Boston based Renovia Inc. in 2016 with the aim of solving the problem of pelvic floor disorder problems in women. Marc Beer raised $42 Million to fund Renovia in a move to make a quality diagnosis and produce better therapeutic devices. Urinary incontinence is one of the most common problems related to pelvic disorders, which affects around 250 Million women globally. In April 2018, FDA approved the Leva, the first product of Renovia Inc. Two companies, Based Ascension Ventures from Missouri and Perspective Advisors from New York together with Longwood Fund formed Series B round. Healthcare focused investor, Longwood Fund, which had invested earlier than the two in Renovia Inc.

 

Series B is a Fund aimed at improving Leva device and testing four more diagnostic and therapeutic products. Commending the move of the three companies, Marc Beer was categorical that there was a good idea combined with the company’s high-level technologies and innovations. He added that the move would boost the company in providing better diagnosis, treatment, and improving the lives of affected women. Additionally, Renovia Inc. is aimed at lowering the long-term healthcare burdens by teaching them about pelvic floor disorder and updating them on any new medication.

 

Marc Beer founded Renovia Inc. together with Yolanda Lorié and Ramon Iglesias. He is the Chairman and the Chief Executive Officer of Renovia Inc. Before forming the company, Marc worked with different biotechnology, diagnostics, devices, and pharmaceutical companies contributing to his 25 years’ experience in the field. Before founding the company, he worked with Viacell, a company, which specialized in matters, related to umbilical cord blood stem cells for seven years. He was a Director of Erytech Pharma, a biopharmaceutical firm.

 

He was also Vice president of Global Marketing at Genzyme and in sales and marketing docket at Abbott Laboratories. Marc also chaired the Boards of Directors of Good Start Genetics Inc. and Minerva Neurosciences Inc. Beer chaired the compensation committees in the two companies. Marc, the BS holder from Miami University in Ohio, was a member of the Business Advisory Council in the University. Through this experience, Beer will take Renovia Inc. to greater heights in helping women with pelvic disorders. Marc Beer mission towards boosting Renovia Inc.with an aim of helping women with the pelvic disorder has not been a simple and easy mission. However, he has been highly devoted and passionate of his success in this mission. Learn more: https://www1.salary.com/Marc-Beer-Salary-Bonus-Stock-Options-for-AEGERION-PHARMACEUTICALS-INC.html